Dr Reddys arm, Olema Pharma ink pact to develop novel cancer therapies Ruchika Sharma10 Jun 2022 12:10 PM ISTDuring the research term, Olema will contribute funding to Aurigene to facilitate ongoing discovery efforts.
Dr Reddys to sell Finast, Styptovit-E and 2 other brands to Torrent Pharma Ruchika Sharma27 May 2022 12:21 PM ISTAs per the terms of the definitive agreement, Torrent Pharma will take over the manufacturing, marketing and distribution of these brands in India.
Dr Reddys, Senores Pharma unveil Ketorolac Tromethamine Tablets in US Ruchika Sharma25 May 2022 11:57 AM ISTDr. Reddy’s Ketorolac Tromethamine Tablets USP, 10 mg, are available in bottle count sizes of 100.
Dr Reddys Labs, HK inno.N Corporation ink pact to commercialize Tegoprazan in India, 6 key emerging Markets Ruchika Sharma12 May 2022 12:19 PM ISTThe agreement grants Dr. Reddy's the exclusive rights to develop and commercialise Tegoprazan under its own trademark in these markets for 10 years...
Ex Dr Reddys President Saumen Chakraborty joins Premas Biotech Board of Directors Ruchika Sharma10 May 2022 11:30 AM ISTSaumen Chakraborty retired as the President and Chief Financial Officer of Dr Reddy’s in 2020 and served as an Advisor to them for the next year.
Dr Reddys, GRA terminate Avigan Trial Study for COVID-19 in Kuwait Ruchika Sharma28 Jan 2021 12:00 PM ISTHyderabad: Dr. Reddy's Laboratories Ltd. and Global Response Aid FZCO (GRA) have recently announced the termination of Avigan Trial Study conducted...
Dr Reddy's Labs to acquire select anti-allergy brands of Glenmark Farhat Nasim29 Nov 2020 4:09 PM ISTThe acquired brands represent two types of products, mometasone mono product and combination of mometasone with azelastine, which are indicated for...
Dr Reddys unveils generic version of Sapropterin Dihydrochloride Tablets in US Ruchika Sharma5 Oct 2020 12:30 PM ISTHyderabad and Princeton: Dr. Reddy's Laboratories Ltd. has recently announced the launch of a generic version of Sapropterin Dihydrochloride Tablets,...
Dr Reddys seeks DCGI approval to conduct Sputnik V Phase-3 clinical trial Ruchika Sharma4 Oct 2020 11:00 AM ISTUpon regulatory approval in India, RDIF will supply to drugmaker Dr Reddy's 100 million doses of the vaccine, the firm said last month.
Dr Reddys launches generic version of Sensipar tablets in US Ruchika Sharma3 Oct 2020 1:30 PM ISTDr. Reddy's Cinacalcet Tablets are available in 30 mg, 60 mg, and 90 mg tablets in a bottle count size of 30.
Dr Reddys unveils multiple sclerosis drug Dimethyl Fumarate Delayed-Release Capsules Ruchika Sharma28 Sept 2020 3:30 PM ISTHyderabad and Princeton: Dr. Reddy's Laboratories Ltd. has recently announced the launch of Dimethyl Fumarate Delayed-Release Capsules, a therapeutic ...
Dr Reddys launches Dexmedetomidine Injection in US Ruchika Sharma27 Sept 2020 10:30 AM ISTHyderabad and Princeton: Drugmaker, Dr. Reddy's Laboratories Ltd., has recently announced the launch of Dexmedetomidine Hydrochloride in 0.9%...
